“Growing need for successful IVF treatments has led to the adoption of advanced technology in Indian market”, says RNCOS

The Indian IVF market is witnessing a large number of technological advancements such as emergence of Care Maps and Embryo Glue. According to a new research report by RNCOS entitled, “Indian IVF & PGD Market, By Structure (Independent, Chained, Hospital-based), by region (North, South, East, and West) – Forecasts to 2022”, the success rate of IVF treatment is bound to rise further due to the novel technologies available which allow the experts to examine the development of embryos closely. For example, Care Maps is one of the most recent add-ons to the IVF technology that has enabled the surgeons to observe the actual developmental progress of the embryo.
Additionally, the Embryo Glue is advancement in the IVF technology that is leading to improved results to the IVF treatment cycle. In this procedure, substances are added to the embryo substrate that results in higher degree of implantation. According to a newly published research from the independent research network, this combination of hyaluronic acid to recombinant albumin in implantation transfer promoting medium increases live births.
Research also showed that, the Array Comparative Genomic Hybridization (CGH) is a new technology that has entered into the IVF treatment cycle recently. This allows for the analysis of the cell in the embryo for chromosome abnormalities. Geographical analysis also revealed that the IVF is more common in Western and Southern India due to rising infertility. On contrary, PGD is more common in Northern and Southern India.
Further adding to the recent developments in the IVF industry in India, researchers concluded that these are unveiling new opportunities for providing improved IVF treatments with high success rates.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM889.htm
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm